Home › Research › Brain scans and imaging
Immediate reactions to amyloid PET disclosure in Japanese older adults without dementia
Kenichiro Sato, Yoshiki Niimi, Ryoko Ihara, Takeshi Ikeuchi, Kenji Ishii, Kengo Ito, Atsushi Iwata, Kensaku Kasuga et al.. Alzheimer's & dementia (New York, N. Y.), 2025-12-19
Topic: Health services, long-term care and technology
Plain-language summary
Twenty-six percent of participants were PET positive. PET-positive individuals experienced greater distress (median IES 8 vs 3) compared with PET-negative peers, whereas FTP improved similarly irrespective of PET status. Concerns about AD increased modestly in PET-positive participants (+4.8%) but decreased in PET-negative individuals (-5.5%; interaction p < 0.001). Female sex and higher baseline depression and anxiety predicted larger distress responses. Consistent with North American and European findings, amyloid PET disclosure in this Japanese cohort was generally well-tolerated, eliciting only modest increases in distress and concerns among PET-positive individuals. These results support the feasibility and ethical acceptability of structured disclosure protocols across cultural settings and highlight the importance of tailored counseling for at-risk subgroups. HIGHLIGHTS: Immediate impact of amyloid disclosure in a Japanese cohort without dementia.Amyloid-positive individuals had higher distress (Impact of Event Scale) after disclosure.Future Time Perspective improved similarly regardless of amyloid positron emission tomography (PET) results.Concerns about Alzheimer's disease slightly rose in PET-positive participants.Female sex and higher baseline depression and anxiety predicted larger distress.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Sato, K., Niimi, Y., Ihara, R., Ikeuchi, T., Ishii, K., Ito, K., et al. (2025). Immediate reactions to amyloid PET disclosure in Japanese older adults without dementia. Alzheimer's & dementia (New York, N. Y.). https://doi.org/10.1002/trc2.70167
Vancouver
Sato K, Niimi Y, Ihara R, Ikeuchi T, Ishii K, Ito K, et al. Immediate reactions to amyloid PET disclosure in Japanese older adults without dementia. Alzheimer's & dementia (New York, N. Y.). 2025. doi:10.1002/trc2.70167. PMID: 41425086.
BibTeX
@article{sato2025-41425086,
author = {Sato, Kenichiro and Niimi, Yoshiki and Ihara, Ryoko and Ikeuchi, Takeshi and Ishii, Kenji and Ito, Kengo and Iwata, Atsushi and Kasuga, Kensaku and others},
title = {{Immediate reactions to amyloid PET disclosure in Japanese older adults without dementia}},
journal = {Alzheimer's \& dementia (New York, N. Y.)},
year = {2025},
doi = {10.1002/trc2.70167},
pmid = {41425086},
url = {https://doi.org/10.1002/trc2.70167}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- Twenty-six percent of participants were PET positive.
- PET-positive individuals experienced greater distress (median IES 8 vs 3) compared with PET-negative peers, whereas FTP improved similarly irrespective of PET status.
- Concerns about AD increased modestly in PET-positive participants (+4.8%) but decreased in PET-negative individuals (-5.5%; interaction p < 0.001).
- Female sex and higher baseline depression and anxiety predicted larger distress responses.
- Consistent with North American and European findings, amyloid PET disclosure in this Japanese cohort was generally well-tolerated, eliciting only modest increases in distress and concerns among PET-positive individuals.
New to this subject? Start with our plain-English guide: Brain scans & tests →
Study details
- Effect size4.8%; 5.5%
- Evidence strengthModerate
How this study scored 54/100
Published in a leading specialty journal. Scored zero for study design, sample size, studied in people and randomized / blinded because the record does not state it. We have no data on journal's citation record, times cited, citations per year, impact for its field and year, cited by studies here, still being cited, senior author's track record, institution's track record, multicenter collaboration and free to read, so those were left out: it earned 30 of the 56 points we could judge it on, which is 54 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 9 / 10 | Tier 2 — leading specialty journal (Alzheimer's & dementia (New York, N. Y.)) |
| Journal's citation record | — / 4 | No journal record from OpenAlex — left out of this score |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 2 / 3 | Effect reported as a number, without an interval or test |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | — / 7 | No citation count (not found in OpenAlex) — left out of this score |
| Citations per year | — / 5 | No citation count or no year — left out of this score |
| Impact for its field and year | — / 6 | No field-weighted citation impact (OpenAlex has none yet) — left out of this score |
| Cited by studies here | — / 6 | Not yet checked against this library's citation graph — left out of this score |
| Still being cited | — / 4 | No yearly citation counts — left out of this score |
| Senior author's track record | — / 4 | Senior author's record not available — left out of this score |
| Institution's track record | — / 3 | No institution listed in OpenAlex — left out of this score |
| Multicenter collaboration | — / 3 | Institutions not listed — left out of this score |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 41425086) |
| Free to read | — / 2 | Access not recorded — left out of this score |
| Points | 30 / 56 | Scored on 10 of 20 parts. We have no data for the rest, so they are left out: 30 of the 56 points we could judge it on is 54 out of 100. |
| Total | 54 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Brain scans and imaging from nearby years
Also tagged “18f”
318 studies in the library carry the topic tag “18f”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 318 tagged studies.